O'Neil Kathleen M
University of Oklahoma Health Sciences Center, Bielstein 2B2316, Oklahoma City, OK 73104, USA.
Curr Rheumatol Rep. 2007 Jun;9(3):205-11. doi: 10.1007/s11926-007-0033-y.
The mechanisms by which an antibody that reacts with phospholipids (universal components of mammalian membranes) causes thrombosis are not immediately obvious. The development of an animal model of antiphospholipid antibody syndrome has moved the field forward in dissecting the pathogenesis of antiphospholipid antibody syndrome and has implicated the complement system in the mechanism of disease. Understanding complement's role in promoting thrombosis will be important in designing safer, more effective approaches to the treatment of patients with antiphospholipid antibodies, and may shed light on which patients are at greatest risk for thrombosis, perhaps permitting primary prophylaxis before irreversible tissue and organ damage occur.
与磷脂(哺乳动物细胞膜的普遍成分)发生反应的抗体引发血栓形成的机制并非一目了然。抗磷脂抗体综合征动物模型的建立推动了该领域对其发病机制的剖析,并表明补体系统参与了疾病机制。了解补体在促进血栓形成中的作用对于设计更安全、更有效的抗磷脂抗体患者治疗方法至关重要,还可能揭示哪些患者血栓形成风险最大,或许能在不可逆的组织和器官损伤发生前进行一级预防。